Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccine”

603 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 603 results

Not applicableWithdrawnNCT00501189
What this trial is testing

Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities

Who this might be right for
Papillomavirus Infections
Eisenhower Army Medical Center
Large-scale testing (Phase 3)Study completedNCT00090285
What this trial is testing

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

Who this might be right for
Condylomata Acuminata
Merck Sharp & Dohme LLC 4,065
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Not applicableStudy completedNCT02276521
What this trial is testing

Evaluation of Long Term Immunity Following HPV Vaccination

Who this might be right for
Cervical CancerAnogenital Warts
Murdoch Childrens Research Institute 200
Large-scale testing (Phase 3)Study completedNCT05254561
What this trial is testing

Triple Antigen vs Monoantigen Immunotherapy for Warts

Who this might be right for
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Zagazig University 160
Large-scale testing (Phase 3)WithdrawnNCT02082639
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00877877
What this trial is testing

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 632
Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Not applicableEnrolling By InvitationNCT06144229
What this trial is testing

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

Who this might be right for
HivHpv
University of California, Los Angeles 650
Large-scale testing (Phase 3)Active Not RecruitingNCT06632912
What this trial is testing

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Who this might be right for
Human Papillomavirus (HPV) InfectionHPV (Human Papillomavirus)-Associated Carcinoma
National Vaccine and Serum Institute, China 1,800
Not applicableLooking for participantsNCT07266857
What this trial is testing

Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students

Who this might be right for
Papillomavirus InfectionPapillomavirus VaccinesVaccination Coveage
Centre Hospitalier Universitaire de Nice 11,000
Large-scale testing (Phase 3)Study completedNCT04772534
What this trial is testing

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 314
Post-approval studies (Phase 4)Study completedNCT02624349
What this trial is testing

Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

Who this might be right for
Late Complication From Kidney TransplantComplication of Transplanted LiverHuman Papillomavirus-Related Carcinoma
The Hospital for Sick Children 37
Testing effectiveness (Phase 2)Study completedNCT04287868
What this trial is testing

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Who this might be right for
Cervical CancerHPV CancersAnal Cancer+2 more
National Cancer Institute (NCI) 51
Not applicableStudy completedNCT04368455
What this trial is testing

Virtual Immersive Communication Training on Recommending Immunizations

Who this might be right for
Human Papilloma Virus
Brittany Rosen 161
Early research (Phase 1)Study completedNCT07081334
What this trial is testing

PV-001 9-valent Human Papillomavirus(HPV) Vaccine

Who this might be right for
HPV Infections
POSVAX 41
Early research (Phase 1)Study completedNCT00257738
What this trial is testing

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Post-approval studies (Phase 4)Study completedNCT01717118
What this trial is testing

Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico

Who this might be right for
Healthy
Instituto Nacional de Salud Publica, Mexico 2,000
Next Page